331 related articles for article (PubMed ID: 2963306)
21. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
Tamura K
Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
[TBL] [Abstract][Full Text] [Related]
22. Meropenem versus ceftazidime plus amikacin in the treatment of febrile episodes in neutropenic patients: a randomized study.
de la Cámara R; Figuera A; Sureda A; Hermida G; Verge G; Olalla I; Fernández Rañada JM; Domingo Albos A
Haematologica; 1997; 82(6):668-75. PubMed ID: 9580087
[TBL] [Abstract][Full Text] [Related]
23. Randomized prospective study of ceftazidime versus ceftazidime plus cephalothin in empiric treatment of febrile episodes in severely neutropenic patients.
Verhagen CS; de Pauw B; de Witte T; Janssen J; Williams K; de Mulder P; Bothof T
Antimicrob Agents Chemother; 1987 Feb; 31(2):191-6. PubMed ID: 3551829
[TBL] [Abstract][Full Text] [Related]
24. Ceftazidime monotherapy is as effective as ceftazidime combined with gentamicin in the treatment of febrile neutropenic patients.
Kinsey SE; Machin SJ; Goldstone AH
J Hosp Infect; 1990 Apr; 15 Suppl A():49-53. PubMed ID: 1971645
[TBL] [Abstract][Full Text] [Related]
25. A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia.
Pizzo PA; Hathorn JW; Hiemenz J; Browne M; Commers J; Cotton D; Gress J; Longo D; Marshall D; McKnight J
N Engl J Med; 1986 Aug; 315(9):552-8. PubMed ID: 3526155
[TBL] [Abstract][Full Text] [Related]
26. Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. A multicenter randomized trial. The Intercontinental Antimicrobial Study Group.
De Pauw BE; Deresinski SC; Feld R; Lane-Allman EF; Donnelly JP
Ann Intern Med; 1994 May; 120(10):834-44. PubMed ID: 8154643
[TBL] [Abstract][Full Text] [Related]
27. [Imipenem/cilastatin versus ceftazidime-amikacin in the treatment of febrile neutropenic patients].
Pérez C; Sirham M; Labarca J; Grebe G; Lira P; Oliva J; Duhalde M; Ocqueteau M; Acuña G
Rev Med Chil; 1995 Mar; 123(3):312-20. PubMed ID: 8525170
[TBL] [Abstract][Full Text] [Related]
28. Monotherapy for empirical management of febrile neutropenic patients.
Rubin M; Pizzo PA
NCI Monogr; 1990; (9):111-6. PubMed ID: 2160613
[TBL] [Abstract][Full Text] [Related]
29. Ceftazidime in the treatment of febrile immunosuppressed children.
Darbyshire PJ; Williamson PJ; Pedler SJ; Speller DC; Mott MG; Oakhill A
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():357-60. PubMed ID: 6352644
[TBL] [Abstract][Full Text] [Related]
30. [Efficacy of the combination of ceftazidime/vancomycin in the first line treatment of infection in neutropenic children].
Schaison G; Leverger G; Pappo M; Chiche D
Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):557-60. PubMed ID: 2200996
[TBL] [Abstract][Full Text] [Related]
31. [Treatment of septicemia and endocarditis with pefloxacine. 15 cases].
Wolff M; Pangon B; Regnier B; Rouveix E; Bauchet J; Vachon F
Presse Med; 1986 Mar; 15(10):471-4. PubMed ID: 2938091
[TBL] [Abstract][Full Text] [Related]
32. [Empirical antibiotic therapy in febrile neutropenic patients with acute leukemia].
Yabe H; Nakamura F; Ishikawa T; Nagai K; Nakayama S
Rinsho Ketsueki; 1989 May; 30(5):644-9. PubMed ID: 2795878
[TBL] [Abstract][Full Text] [Related]
33. Piperacillin plus amikacin versus cefotaxime plus amikacin in neutropenic and feverish patients with malignant hemopathies.
Pavone V; Specchia G; Guarini A; Coniglio M; Iaculli L; Girardi F; Colucci A; Liso V
Chemioterapia; 1988 Oct; 7(5):330-5. PubMed ID: 3224402
[TBL] [Abstract][Full Text] [Related]
34. A randomized prospective study of ceftazidime and ciprofloxacin with or without teicoplanin as an empiric antibiotic regimen for febrile neutropenic patients.
Lim SH; Smith MP; Goldstone AH; Machin SJ
Br J Haematol; 1990 Dec; 76 Suppl 2():41-4. PubMed ID: 2149051
[TBL] [Abstract][Full Text] [Related]
35. Ceftazidime alone for treating Pseudomonas aeruginosa septicaemia in neutropenic patients.
Verhagen C; de Pauw BE; Donnelly JP; Williams KJ; de Witte T; Janssen TH
J Infect; 1986 Sep; 13(2):125-31. PubMed ID: 3093589
[TBL] [Abstract][Full Text] [Related]
36. Cost-effectiveness of cefepime + netilmicin or ceftazidime + amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey.
Agaoglu L; Devecioglu O; Anak S; Karakas Z; Yalman N; Biner B; Eryilmaz E; Goksan B; Unuvar A; Agirbasli H; Can M; Bilgen H; Gedikoglu G
J Chemother; 2001 Jun; 13(3):281-7. PubMed ID: 11450887
[TBL] [Abstract][Full Text] [Related]
37. Use of ceftazidime in febrile incidents in immunocompromised haematological patients.
d'Oliveira JJ; Pereira ME; Mateus LM; Monteiro JM; Parreira AS; Soares AD
J Int Med Res; 1986; 14(1):30-4. PubMed ID: 3514313
[TBL] [Abstract][Full Text] [Related]
38. Clostridium tertium septicemia in patients with neutropenia.
Speirs G; Warren RE; Rampling A
J Infect Dis; 1988 Dec; 158(6):1336-40. PubMed ID: 3198941
[TBL] [Abstract][Full Text] [Related]
39. Ceftazidime in acute myeloid leukemia patients with febrile neutropenia: helpfulness of continuous intravenous infusion in maximizing pharmacodynamic exposure.
Pea F; Viale P; Damiani D; Pavan F; Cristini F; Fanin R; Furlanut M
Antimicrob Agents Chemother; 2005 Aug; 49(8):3550-3. PubMed ID: 16048982
[TBL] [Abstract][Full Text] [Related]
40. Antibiotic use in neonatal sepsis.
Yurdakök M
Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
